COMPANY

Slam BioTherapeutics

HQ: Westlake Village, CA source · slambio.com ↗

Keywords: antibody antibody-drug conjugate oncology hematology immunology ADC blood cancers hematologic malignancies acute myeloid leukemia

Location: Westlake Village, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $1M in debt securities (Form D filed Dec 29, 2025). SEC Form D 0001983523-25-000004 (Dec 29, 2025)
Evidence (1 event)
- Dec 29, 2025 · SEC Form D 0001983523-25-000004
  Name of Issuer: SLAM BioTherapeutics, Inc.; CIK: 1983523; Address: Westlake Village, CA; Submission type: D; Filing date: 2025-12-29; Industry Group: Biotechnology; Date of First Sale: 2025-12-19; Types of Securities Offered: Debt, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 1000000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals